NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|528479212|ref|XP_005171857|]
View 

endoplasmic reticulum aminopeptidase 1b isoform X1 [Danio rerio]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats is a zinc-dependent metallopeptidase with an HEXXH motif as part of its active site, similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

EC:  3.4.11.-
Gene Ontology:  GO:0008237|GO:0008270|GO:0006508
MEROPS:  M1

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
54-523 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 626.14  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  54 LHYNLLIHPNLTSLDFTGSVQIQIEVLQDTKTIILHSKNLQISSARLLDANIAQQQPLKVLEYPYFQQIALVSDKALlKR 133
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETL-PP 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 134 GHVYSVELHFAANLSESFHGFYKSTYRTSKGDVRVVASTQFEATSARAAFPCFDEPAFKANFSVQIRREAKHIALSNMPK 213
Cdd:cd09601   80 GENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPP 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 214 LRTLELKNGLFEDQFDVSVKMSTYLVAYIVSDFLSISKTSQHGVQISVYAVPEKIDQAEFALDAAVKLLDFYDDYFDIPY 293
Cdd:cd09601  160 VESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPY 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 294 PLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDPHKSSASDKLGITMIIAHELAHQWFGNLVTMQWWNDLWLNEGFAKF 373
Cdd:cd09601  240 PLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATY 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 374 MEFVSVNITNPELQVEDYFL-GKCFEAMEVDSLSSSHPVSTPVENPAQIQEMFDDVSYDKGACILNMLREFLTPKIFKLG 452
Cdd:cd09601  320 MEYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKG 399
                        410       420       430       440       450       460       470
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 528479212 453 IVKYLKHYSYQNTVNSNLWESLTNVCDSDgldegrlkgdescrhsasntgaskwhseDELDVKAMMETWTL 523
Cdd:cd09601  400 LRKYLKKHAYGNATTDDLWEALQEASGES----------------------------KPLDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
594-914 6.16e-85

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 275.69  E-value: 6.16e-85
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  594 WIKFNVDMSGYYIVHYEGSGWDDLITLLkhNHTALSSNDRASLINNAFQLVSVGKLPLDKALDLTLYLSKETEIMPVTQG 673
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  674 FNELVPLYKLMEKRDMVElenQMKGYILQLFQKLIEQQLWTDEG--SVSERMLRSYLLLFGCVRGHPPCVSNATQLFNLW 751
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYE---ALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  752 RDSDGNmsLPNDVTMAVFSVGAR--TEDGWDFLFEKYKESMYVSMKSRIKQALMTSPLDHKLKWMMEQSLEGELIKTQDL 829
Cdd:pfam11838 156 LDGDDA--IPPDLRWAVYCAAVAngGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  830 PYVVTSVSRNPKAYKHAWDFLQANWDSLIKKFDlGSHSIAHMVVGVTNQYSTREMLAEVRNFFSlLQPETGAElRCIQQA 909
Cdd:pfam11838 234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLG-GGSSLGRLVKGLTPSFSTEEELDEVEAFFA-DKDTPGLR-RALAQA 310

                  ....*
gi 528479212  910 VENIE 914
Cdd:pfam11838 311 LETIR 315
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
54-523 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 626.14  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  54 LHYNLLIHPNLTSLDFTGSVQIQIEVLQDTKTIILHSKNLQISSARLLDANIAQQQPLKVLEYPYFQQIALVSDKALlKR 133
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETL-PP 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 134 GHVYSVELHFAANLSESFHGFYKSTYRTSKGDVRVVASTQFEATSARAAFPCFDEPAFKANFSVQIRREAKHIALSNMPK 213
Cdd:cd09601   80 GENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPP 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 214 LRTLELKNGLFEDQFDVSVKMSTYLVAYIVSDFLSISKTSQHGVQISVYAVPEKIDQAEFALDAAVKLLDFYDDYFDIPY 293
Cdd:cd09601  160 VESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPY 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 294 PLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDPHKSSASDKLGITMIIAHELAHQWFGNLVTMQWWNDLWLNEGFAKF 373
Cdd:cd09601  240 PLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATY 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 374 MEFVSVNITNPELQVEDYFL-GKCFEAMEVDSLSSSHPVSTPVENPAQIQEMFDDVSYDKGACILNMLREFLTPKIFKLG 452
Cdd:cd09601  320 MEYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKG 399
                        410       420       430       440       450       460       470
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 528479212 453 IVKYLKHYSYQNTVNSNLWESLTNVCDSDgldegrlkgdescrhsasntgaskwhseDELDVKAMMETWTL 523
Cdd:cd09601  400 LRKYLKKHAYGNATTDDLWEALQEASGES----------------------------KPLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
46-642 4.07e-115

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 365.89  E-value: 4.07e-115
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  46 RLPDTISPLHYNLLIHPNLTSLDFTGSVQIQIEVLQD-TKTIILHSKNLQISSARLLDANIAQQQPLKVLEypyfqqial 124
Cdd:COG0308   10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEApLDSLVLDLKGLEVTSVTVDGKPLDFTRDGERLT--------- 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 125 VSDKALLKRGHVYSVELHFAANLSESFHGFYKSTYRtskGDVRVVASTQFEATSARAAFPCFDEPAFKANFSVQIRREAK 204
Cdd:COG0308   81 ITLPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGDP---PDGPPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVPAG 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 205 HIALSNMPKLRTLELKNGLFEDQFDVSVKMSTYLVAYIVSDFLSISKTSQHGVQISVYAVPEKIDQAEFALDAAVKLLDF 284
Cdd:COG0308  158 WVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAKEAFESTKRMLDF 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 285 YDDYFDIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDphKSSASDKLGITMIIAHELAHQWFGNLVTMQWWNDL 364
Cdd:COG0308  238 FEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVLADE--TATDADYERRESVIAHELAHQWFGNLVTCADWDDL 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 365 WLNEGFAKFMEFVSVNITNPELQVEDYFLGKCFE-AMEVDSLSSSHPVStpVENPAQIQEMFDDVSYDKGACILNMLREF 443
Cdd:COG0308  316 WLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSyAFAEDAGPNAHPIR--PDDYPEIENFFDGIVYEKGALVLHMLRTL 393
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 444 LTPKIFKLGIVKYLKHYSYQNTVNSNLWESLTNVCdsdgldeGRlkgdescrhsasntgaskwhsedelDVKAMMETWTL 523
Cdd:COG0308  394 LGDEAFRAGLRLYFARHAGGNATTEDFLAALEEAS-------GR-------------------------DLSAFFDQWLY 441
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 524 QEGFPLITIAV-----KGREVRLSQERYLKSddlsqtssfLWQVPLTYITSDSTTVHRFLLKTKTDVlYLPEEVDWIKfn 598
Cdd:COG0308  442 QAGLPTLEVEYeydadGKVTLTLRQTPPRPH---------PFHIPLEVGLLGGKLTARTVLLDGEQT-ELVAKPDPVL-- 509
                        570       580       590       600
                 ....*....|....*....|....*....|....*....|....
gi 528479212 599 vdmsgyyIVHYEgsgwDDLITLLKHNHTALssnDRASLINNAFQ 642
Cdd:COG0308  510 -------LLRLD----DELAFLLAHDSDPF---NRWEALQALWR 539
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
273-485 6.60e-95

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 298.43  E-value: 6.60e-95
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  273 FALDAAVKLLDFYDDYFDIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDPHKSSASDKLGITMIIAHELAHQWF 352
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  353 GNLVTMQWWNDLWLNEGFAKFMEFVSVNITNPELQV-EDYFLGKCFEAMEVDSLSSSHPVSTPVENPAQIQEMFDDVSYD 431
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIwEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....
gi 528479212  432 KGACILNMLREFLTPKIFKLGIVKYLKHYSYQNTVNSNLWESLTNVCDSDGLDE 485
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGPLDVDS 214
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
594-914 6.16e-85

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 275.69  E-value: 6.16e-85
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  594 WIKFNVDMSGYYIVHYEGSGWDDLITLLkhNHTALSSNDRASLINNAFQLVSVGKLPLDKALDLTLYLSKETEIMPVTQG 673
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  674 FNELVPLYKLMEKRDMVElenQMKGYILQLFQKLIEQQLWTDEG--SVSERMLRSYLLLFGCVRGHPPCVSNATQLFNLW 751
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYE---ALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  752 RDSDGNmsLPNDVTMAVFSVGAR--TEDGWDFLFEKYKESMYVSMKSRIKQALMTSPLDHKLKWMMEQSLEGELIKTQDL 829
Cdd:pfam11838 156 LDGDDA--IPPDLRWAVYCAAVAngGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  830 PYVVTSVSRNPKAYKHAWDFLQANWDSLIKKFDlGSHSIAHMVVGVTNQYSTREMLAEVRNFFSlLQPETGAElRCIQQA 909
Cdd:pfam11838 234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLG-GGSSLGRLVKGLTPSFSTEEELDEVEAFFA-DKDTPGLR-RALAQA 310

                  ....*
gi 528479212  910 VENIE 914
Cdd:pfam11838 311 LETIR 315
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
116-681 7.93e-66

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 237.38  E-value: 7.93e-66
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  116 YPYFQ--QIALvsdKALLKRGHVYSVELHFA-ANLSESFHGFykstyrTSKGDVRVVASTQFEATSARAAFPCFDEPAFK 192
Cdd:TIGR02412  72 APVYDgsRIPL---PGLLTGENTLRVEATRAyTNTGEGLHRF------VDPVDGEVYLYTQFEPADARRVFAVFDQPDLK 142
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  193 ANFSVQIRREAKHIALSN-MPKLRTLELKNGLFEdqFDVSVKMSTYLVAYIVSDFLSISKTSQhGVQISVYA---VPEKI 268
Cdd:TIGR02412 143 ANFKFSVKAPEDWTVISNsRETDVTPEPADRRWE--FPETPKLSTYLTAVAAGPYHSVQDESR-SYPLGIYArrsLAQYL 219
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  269 DqAEFALDAAVKLLDFYDDYFDIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALlfdpHKSSASD--KLGITMIIAHE 346
Cdd:TIGR02412 220 D-ADAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFL----HRAEATRaeKENRAGVILHE 294
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  347 LAHQWFGNLVTMQWWNDLWLNEGFAKFME-FVSVNITNPELQVEDYFLGKCFEAMEVDSLSSSHPVSTPVENPAQIQEMF 425
Cdd:TIGR02412 295 MAHMWFGDLVTMRWWNDLWLNESFAEYMGtLASAEATEYTDAWTTFAAQGKQWAYEADQLPTTHPIVADVADLADALSNF 374
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  426 DDVSYDKGACILNMLREFLTPKIFKLGIVKYLKHYSYQNTVNSNLWESLTNVCDSDgLDEGRlkgDESCRHSASNTGASK 505
Cdd:TIGR02412 375 DGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDSLAKASGRD-LSAWS---DAWLETAGVNTLTPE 450
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  506 WHSEDeldvkammetwtlqEGFPLITIAVKG--REVRLSQERY-LKSDDLSQTSsflwQVPLTyITSDSTTVHRFLLKTK 582
Cdd:TIGR02412 451 ITTDG--------------GVVSALYPESSGppRPHRIAIGLYdLDRDDLRRTT----LVPLT-ISGERTAVPQLVGKRA 511
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  583 TDVLYLPEEvDWikfnvdmsGYYIVHYEGSGWDDLITLLKHNHTALSsndRASLINNAFQLVSVGKLPLDKALDL-TLYL 661
Cdd:TIGR02412 512 PALVLLNDD-DL--------TYAKVRLDPTSFDTVLAALSKLPDPLS---RAVVWASLWDSVRDGELSPDDYLSTvFAHV 579
                         570       580
                  ....*....|....*....|
gi 528479212  662 SKETEIMPVTQGFNELVPLY 681
Cdd:TIGR02412 580 PSETDYAVVQQVLSQLLRAV 599
pepN PRK14015
aminopeptidase N; Provisional
257-460 1.50e-08

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 58.60  E-value: 1.50e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 257 VQISVYAVPEKIDQAEFALDA---AVKlldfYD-DYFDIPYplpkqDL-----AAIPDFQSGAMENWGLTTYRESALLFD 327
Cdd:PRK14015 214 VALEIYVEPGNLDKCDHAMDSlkkSMK----WDeERFGLEY-----DLdifmiVAVDDFNMGAMENKGLNIFNSKYVLAD 284
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 328 PHksSASDK--LGITMIIAHELAHQWFGNLVTMQWWNDLWLNEGFAKF--MEFVS------VN-ITN---------PElq 387
Cdd:PRK14015 285 PE--TATDAdyERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFrdQEFSAdlgsraVKrIEDvrvlraaqfAE-- 360
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 528479212 388 vedyflgkcfeamevDSLSSSHPVstpveNPAQIQEM--FDDVS-YDKGACILNMLREFLTPKIFKLGIVKYLKHY 460
Cdd:PRK14015 361 ---------------DAGPMAHPV-----RPDSYIEInnFYTATvYEKGAEVIRMLHTLLGEEGFRKGMDLYFERH 416
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
54-523 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 626.14  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  54 LHYNLLIHPNLTSLDFTGSVQIQIEVLQDTKTIILHSKNLQISSARLLDANIAQQQPLKVLEYPYFQQIALVSDKALlKR 133
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETL-PP 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 134 GHVYSVELHFAANLSESFHGFYKSTYRTSKGDVRVVASTQFEATSARAAFPCFDEPAFKANFSVQIRREAKHIALSNMPK 213
Cdd:cd09601   80 GENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPP 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 214 LRTLELKNGLFEDQFDVSVKMSTYLVAYIVSDFLSISKTSQHGVQISVYAVPEKIDQAEFALDAAVKLLDFYDDYFDIPY 293
Cdd:cd09601  160 VESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPY 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 294 PLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDPHKSSASDKLGITMIIAHELAHQWFGNLVTMQWWNDLWLNEGFAKF 373
Cdd:cd09601  240 PLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATY 319
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 374 MEFVSVNITNPELQVEDYFL-GKCFEAMEVDSLSSSHPVSTPVENPAQIQEMFDDVSYDKGACILNMLREFLTPKIFKLG 452
Cdd:cd09601  320 MEYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKG 399
                        410       420       430       440       450       460       470
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 528479212 453 IVKYLKHYSYQNTVNSNLWESLTNVCDSDgldegrlkgdescrhsasntgaskwhseDELDVKAMMETWTL 523
Cdd:cd09601  400 LRKYLKKHAYGNATTDDLWEALQEASGES----------------------------KPLDVKEIMDSWTL 442
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
55-474 4.01e-132

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 403.36  E-value: 4.01e-132
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  55 HYNLLIHPNLTSLDFTGSVQIQIEVLQDTKTIILHSKNLQISSArllDANIAQQQPLKvLEYPYFQQIALVSDKALLKRg 134
Cdd:cd09595    2 HYDLDLDVDFTTKTLNGTETLTVDASQVGRELVLDLVGLTIHSV---SVNGAAVDFGE-REHYDGEKLTIPGPKPPGQT- 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 135 hvYSVELHFAANLSESFHGFYKSTYrtsKGDVRVVASTQFEATSARAAFPCFDEPAFKANFSVQIRREAKHIALSNMPKL 214
Cdd:cd09595   77 --FTVRISFEAKPSKNLLGWLWEQT---AGKEKPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPKKDLLASNGALV 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 215 RTLELKNGLFEDQFDVSVKMSTYLVAYIVSDFLSISKT--SQHGVQISVYAVPEKIDQAEFALDAAVKLLDFYDDYFDIP 292
Cdd:cd09595  152 GEETGANGRKTYRFEDTPPIPTYLVAVVVGDLEFKYVTvkSQPRVGLSVYSEPLQVDQAQYAFDATRAALAWFEDYFGGP 231
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 293 YPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDphKSSASDKLGITMIIAHELAHQWFGNLVTMQWWNDLWLNEGFAK 372
Cdd:cd09595  232 YPLPKYDLLAVPDFNSGAMENPGLITFRTTYLLRS--KVTDTGARSIENVIAHELAHQWFGNLVTMRWWNDLWLNEGFAV 309
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 373 FMEFVSVNITNPELQVEDYFLGKCFEAMEVDSLSSSHPVSTPVENPAQIQEMFDDVSYDKGACILNMLREFLTPKIFKLG 452
Cdd:cd09595  310 YYENRIMDATFGTSSRHLDQLSGSSDLNTEQLLEDSSPTSTPVRSPADPDVAYDGVTYAKGALVLRMLEELVGEEAFDKG 389
                        410       420
                 ....*....|....*....|..
gi 528479212 453 IVKYLKHYSYQNTVNSNLWESL 474
Cdd:cd09595  390 VQAYFNRHKFKNATTDDFIDAL 411
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
46-642 4.07e-115

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 365.89  E-value: 4.07e-115
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  46 RLPDTISPLHYNLLIHPNLTSLDFTGSVQIQIEVLQD-TKTIILHSKNLQISSARLLDANIAQQQPLKVLEypyfqqial 124
Cdd:COG0308   10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEApLDSLVLDLKGLEVTSVTVDGKPLDFTRDGERLT--------- 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 125 VSDKALLKRGHVYSVELHFAANLSESFHGFYKSTYRtskGDVRVVASTQFEATSARAAFPCFDEPAFKANFSVQIRREAK 204
Cdd:COG0308   81 ITLPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGDP---PDGPPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVPAG 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 205 HIALSNMPKLRTLELKNGLFEDQFDVSVKMSTYLVAYIVSDFLSISKTSQHGVQISVYAVPEKIDQAEFALDAAVKLLDF 284
Cdd:COG0308  158 WVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAKEAFESTKRMLDF 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 285 YDDYFDIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDphKSSASDKLGITMIIAHELAHQWFGNLVTMQWWNDL 364
Cdd:COG0308  238 FEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVLADE--TATDADYERRESVIAHELAHQWFGNLVTCADWDDL 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 365 WLNEGFAKFMEFVSVNITNPELQVEDYFLGKCFE-AMEVDSLSSSHPVStpVENPAQIQEMFDDVSYDKGACILNMLREF 443
Cdd:COG0308  316 WLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSyAFAEDAGPNAHPIR--PDDYPEIENFFDGIVYEKGALVLHMLRTL 393
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 444 LTPKIFKLGIVKYLKHYSYQNTVNSNLWESLTNVCdsdgldeGRlkgdescrhsasntgaskwhsedelDVKAMMETWTL 523
Cdd:COG0308  394 LGDEAFRAGLRLYFARHAGGNATTEDFLAALEEAS-------GR-------------------------DLSAFFDQWLY 441
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 524 QEGFPLITIAV-----KGREVRLSQERYLKSddlsqtssfLWQVPLTYITSDSTTVHRFLLKTKTDVlYLPEEVDWIKfn 598
Cdd:COG0308  442 QAGLPTLEVEYeydadGKVTLTLRQTPPRPH---------PFHIPLEVGLLGGKLTARTVLLDGEQT-ELVAKPDPVL-- 509
                        570       580       590       600
                 ....*....|....*....|....*....|....*....|....
gi 528479212 599 vdmsgyyIVHYEgsgwDDLITLLKHNHTALssnDRASLINNAFQ 642
Cdd:COG0308  510 -------LLRLD----DELAFLLAHDSDPF---NRWEALQALWR 539
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
273-485 6.60e-95

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 298.43  E-value: 6.60e-95
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  273 FALDAAVKLLDFYDDYFDIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDPHKSSASDKLGITMIIAHELAHQWF 352
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  353 GNLVTMQWWNDLWLNEGFAKFMEFVSVNITNPELQV-EDYFLGKCFEAMEVDSLSSSHPVSTPVENPAQIQEMFDDVSYD 431
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIwEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....
gi 528479212  432 KGACILNMLREFLTPKIFKLGIVKYLKHYSYQNTVNSNLWESLTNVCDSDGLDE 485
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGPLDVDS 214
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
594-914 6.16e-85

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 275.69  E-value: 6.16e-85
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  594 WIKFNVDMSGYYIVHYEGSGWDDLITLLkhNHTALSSNDRASLINNAFQLVSVGKLPLDKALDLTLYLSKETEIMPVTQG 673
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  674 FNELVPLYKLMEKRDMVElenQMKGYILQLFQKLIEQQLWTDEG--SVSERMLRSYLLLFGCVRGHPPCVSNATQLFNLW 751
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYE---ALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  752 RDSDGNmsLPNDVTMAVFSVGAR--TEDGWDFLFEKYKESMYVSMKSRIKQALMTSPLDHKLKWMMEQSLEGELIKTQDL 829
Cdd:pfam11838 156 LDGDDA--IPPDLRWAVYCAAVAngGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  830 PYVVTSVSRNPKAYKHAWDFLQANWDSLIKKFDlGSHSIAHMVVGVTNQYSTREMLAEVRNFFSlLQPETGAElRCIQQA 909
Cdd:pfam11838 234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLG-GGSSLGRLVKGLTPSFSTEEELDEVEAFFA-DKDTPGLR-RALAQA 310

                  ....*
gi 528479212  910 VENIE 914
Cdd:pfam11838 311 LETIR 315
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
50-481 2.48e-84

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 278.24  E-value: 2.48e-84
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  50 TISPLHYNLLIhpNLTSLD--FTGSVQIQIEVLQDTKTIILHSKNLQISSARLLDaniaqqqplKVLEYPYFQ--QIALv 125
Cdd:cd09602   12 LISVVSYDLDL--DLTEGAetFRGTVTIRFTLREPGASLFLDFRGGEVKSVTLNG---------RPLDPSAFDgeRITL- 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 126 sdKALLKRGHVySVELHFAA---NLSESFHGFykstyrTSKGDVRVVASTQFEATSARAAFPCFDEPAFKANFSVQIRRE 202
Cdd:cd09602   80 --PGLLKAGEN-TVVVEFTApysSDGEGLHRF------VDPADGETYLYTLFEPDDARRVFPCFDQPDLKATFTLTVTAP 150
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 203 AKHIALSNMPKLRTLELKNGLFEdQFDVSVKMSTYLVAYIVSDFLSISKTSQhGVQISVYA---VPEKIDQAEFALDAAV 279
Cdd:cd09602  151 ADWTVISNGPETSTEEAGGRKRW-RFAETPPLSTYLFAFVAGPYHRVEDEHD-GIPLGLYCresLAEYERDADEIFEVTK 228
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 280 KLLDFYDDYFDIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDPhkSSASDKLGITMIIAHELAHQWFGNLVTMQ 359
Cdd:cd09602  229 QGLDFYEDYFGIPYPFGKYDQVFVPEFNFGAMENPGAVTFRESYLFREE--PTRAQRLRRANTILHEMAHMWFGDLVTMK 306
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 360 WWNDLWLNEGFAKFMefvSVNITNPELQVEDYFLGkcFE------AMEVDSLSSSHPVSTPVENPAQIQEMFDDVSYDKG 433
Cdd:cd09602  307 WWDDLWLNESFADFM---AAKALAEATPFTDAWLT--FLlrrkpwAYRADQLPTTHPIAQDVPDLEAAGSNFDGITYAKG 381
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|....*...
gi 528479212 434 ACILNMLREFLTPKIFKLGIVKYLKHYSYQNTVNSNLWESLTNVCDSD 481
Cdd:cd09602  382 ASVLKQLVALVGEEAFRAGLREYFKKHAYGNATLDDLIAALDEASGRD 429
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
116-681 7.93e-66

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 237.38  E-value: 7.93e-66
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  116 YPYFQ--QIALvsdKALLKRGHVYSVELHFA-ANLSESFHGFykstyrTSKGDVRVVASTQFEATSARAAFPCFDEPAFK 192
Cdd:TIGR02412  72 APVYDgsRIPL---PGLLTGENTLRVEATRAyTNTGEGLHRF------VDPVDGEVYLYTQFEPADARRVFAVFDQPDLK 142
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  193 ANFSVQIRREAKHIALSN-MPKLRTLELKNGLFEdqFDVSVKMSTYLVAYIVSDFLSISKTSQhGVQISVYA---VPEKI 268
Cdd:TIGR02412 143 ANFKFSVKAPEDWTVISNsRETDVTPEPADRRWE--FPETPKLSTYLTAVAAGPYHSVQDESR-SYPLGIYArrsLAQYL 219
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  269 DqAEFALDAAVKLLDFYDDYFDIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALlfdpHKSSASD--KLGITMIIAHE 346
Cdd:TIGR02412 220 D-ADAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFL----HRAEATRaeKENRAGVILHE 294
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  347 LAHQWFGNLVTMQWWNDLWLNEGFAKFME-FVSVNITNPELQVEDYFLGKCFEAMEVDSLSSSHPVSTPVENPAQIQEMF 425
Cdd:TIGR02412 295 MAHMWFGDLVTMRWWNDLWLNESFAEYMGtLASAEATEYTDAWTTFAAQGKQWAYEADQLPTTHPIVADVADLADALSNF 374
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  426 DDVSYDKGACILNMLREFLTPKIFKLGIVKYLKHYSYQNTVNSNLWESLTNVCDSDgLDEGRlkgDESCRHSASNTGASK 505
Cdd:TIGR02412 375 DGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDSLAKASGRD-LSAWS---DAWLETAGVNTLTPE 450
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  506 WHSEDeldvkammetwtlqEGFPLITIAVKG--REVRLSQERY-LKSDDLSQTSsflwQVPLTyITSDSTTVHRFLLKTK 582
Cdd:TIGR02412 451 ITTDG--------------GVVSALYPESSGppRPHRIAIGLYdLDRDDLRRTT----LVPLT-ISGERTAVPQLVGKRA 511
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  583 TDVLYLPEEvDWikfnvdmsGYYIVHYEGSGWDDLITLLKHNHTALSsndRASLINNAFQLVSVGKLPLDKALDL-TLYL 661
Cdd:TIGR02412 512 PALVLLNDD-DL--------TYAKVRLDPTSFDTVLAALSKLPDPLS---RAVVWASLWDSVRDGELSPDDYLSTvFAHV 579
                         570       580
                  ....*....|....*....|
gi 528479212  662 SKETEIMPVTQGFNELVPLY 681
Cdd:TIGR02412 580 PSETDYAVVQQVLSQLLRAV 599
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
54-464 3.62e-55

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 197.04  E-value: 3.62e-55
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  54 LHYNLLIHPNLTSLDFTGSVQIQIEVLQDTKTIILHSKNLQISSARLLDAniaqqqplkvlEYPYFQQIA---LVSDKAL 130
Cdd:cd09603    4 LHYDLDLDYDPATKSLSGTATITFRATQDLDSLQLDLVGLTVSSVTVDGV-----------PAAFFTHDGdklVITLPRP 72
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 131 LKRGHVYSVELHFAAN--LSESFHGFYKSTYRTSKGdvrvvASTQFEATSARAAFPCFDEPAFKANFSVQIRREAKHIAL 208
Cdd:cd09603   73 LAAGETFTVTVRYSGKprPAGYPPGDGGGWEEGDDG-----VWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGLTVV 147
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 209 SNMPKLRTLELKNGLFEDQFDVSVKMSTYLVAYIVSDFLSISKTSQHGVQISVYAVPEKIDQAEFALDAAVKLLDFYDDY 288
Cdd:cd09603  148 SNGRLVSTTTNGGGTTTWHWKMDYPIATYLVTLAVGRYAVVEDGSGGGIPLRYYVPPGDAAKAKASFARTPEMLDFFEEL 227
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 289 FdIPYPLPKQDLAAIPDFqSGAMENWGLTTYRESALLFDPhkssASDKLgitmiIAHELAHQWFGNLVTMQWWNDLWLNE 368
Cdd:cd09603  228 F-GPYPFEKYGQVVVPDL-GGGMEHQTATTYGNNFLNGDR----GSERL-----IAHELAHQWFGDSVTCADWADIWLNE 296
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 369 GFAKFMEFVSVNitnpELQVEDYFLGKCFEAMevDSLSSSHPVSTPVENPAqiqEMFDDVSYDKGACILNMLREFLTPKI 448
Cdd:cd09603  297 GFATYAEWLWSE----HKGGADAYRAYLAGQR--QDYLNADPGPGRPPDPD---DLFDRDVYQKGALVLHMLRNLLGDEA 367
                        410
                 ....*....|....*.
gi 528479212 449 FKLGIVKYLKHYSYQN 464
Cdd:cd09603  368 FFAALRAYLARYAHGN 383
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
52-238 2.28e-50

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 175.61  E-value: 2.28e-50
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212   52 SPLHYNLLIHPNLTSLDFTGSVQIQIEVLQDTKTIILHSKNLQISSARLLDANIAQQQPLKVLEYPYFQQIALVSDKALL 131
Cdd:pfam17900   1 VPEHYDLDLKIDLKNFTFSGSVTITLQLNNATNVIVLHASDLTIRSISLSDEVTSDGVPADFTEDQKDGEKLTIVLPETL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  132 KRGHVYSVELHFAANLSESFHGFYKSTYrTSKGDVRVVASTQFEATSARAAFPCFDEPAFKANFSVQIRREAKHIALSNM 211
Cdd:pfam17900  81 NQTGPYTLEIEYSGELNDSMTGFYRSTY-TDNGEKKVLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHPKDYTALSNM 159
                         170       180
                  ....*....|....*....|....*..
gi 528479212  212 PKLRTLELKNGLFEDQFDVSVKMSTYL 238
Cdd:pfam17900 160 PVIASEPLENGWVITTFEQTPKMSTYL 186
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
48-471 6.01e-35

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 139.13  E-value: 6.01e-35
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  48 PDTISPLHYNLlihpNLTsLDF-----TGSVQIQIEVLQD-TKTIILHSKNLQISSARLLDANIAQQQpLKVLEYPYFQQ 121
Cdd:cd09599    8 YDEVRTTHLDL----DLT-VDFdkktiSGSATLTLEVLQDgADELVLDTRDLDISSVTVNGGKELKFE-LGPRDPVLGSA 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 122 IaLVSDKALLKRGHVYSVELhfaanlsesfhgfyksTYRTSKGdvrvvAS-------------------TQFEATSARAA 182
Cdd:cd09599   82 L-TITLPSPLAKGDTFKVKI----------------EYSTTPQ-----ATalqwltpeqtagkkhpylfTQCQAIHARSL 139
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 183 FPCFDEPAFKANFSVQIRREAKHIAL-SNMPKLRTLELKNGLFedQFDVSVKMSTYLVAYIVSD--FLSISKTSqhgvqi 259
Cdd:cd09599  140 FPCQDTPSVKSTYSATVTVPKGLTALmSALRTGEKEEAGTGTY--TFEQPVPIPSYLIAIAVGDleSREIGPRS------ 211
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 260 SVYAVPEKIDQA--EFA-----LDAAVKLLdfyddyfdIPYP--------LPkqdlaaiPDFQSGAMENWGLT--TyreS 322
Cdd:cd09599  212 GVWAEPSVVDAAaeEFAdtekfLKAAEKLY--------GPYVwgrydllvLP-------PSFPYGGMENPCLTfaT---P 273
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 323 ALLfdphkssASDKLGITmIIAHELAHQWFGNLVTMQWWNDLWLNEGFAKFMEfvsvNITNPELQVEDYF---------- 392
Cdd:cd09599  274 TLI-------AGDRSLVD-VIAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLE----RRILERLYGEEYRqfeailgwkd 341
                        410       420       430       440       450       460       470
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 528479212 393 LGKCFEAMEVDSLSSSHPVSTPVENPaqiQEMFDDVSYDKGACILNMLREFLTPKIFKLGIVKYLKHYSYQnTVNSNLW 471
Cdd:cd09599  342 LQESIKEFGEDPPYTLLVPDLKGVDP---DDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQ-SIDTEDF 416
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
139-460 8.92e-30

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 123.39  E-value: 8.92e-30
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 139 VELHFAANLSESfhGFYKStyrtskGDVRVvasTQFEATSARAAFPCFDEPAFKANFSVQIRREAKH--IALSNMPKLRT 216
Cdd:cd09600   89 VRINPAANTSLE--GLYKS------GGILC---TQCEAEGFRRITYFPDRPDVMSKFTVTIEADKEKypVLLSNGNLIEE 157
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 217 LELKNGL----FEDQFdvsvKMSTYLVAYIVSDFLSISKT----SQHGVQISVYAVPEKIDQAEFALDAAVKLLDFYDDY 288
Cdd:cd09600  158 GELPNGRhfavWEDPF----PKPSYLFALVAGDLGSVEDTfttkSGRKVKLRIYVEPGNEDKCHHAMESLKKAMKWDEER 233
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 289 FDIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDPHKSSASDKLGITMIIAHELAHQWFGNLVTMQWWNDLWLNE 368
Cdd:cd09600  234 FGLEYDLDLFNIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKE 313
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 369 GFAKF--MEFvSVNITNPELQ-VEDYFLGKCFEAMEvDSLSSSHPVstpveNPAQIQEM--FDDVS-YDKGACILNMLRE 442
Cdd:cd09600  314 GLTVFrdQEF-SADMNSRAVKrIEDVRRLRSAQFPE-DAGPMAHPI-----RPDSYIEInnFYTVTvYEKGAEVIRMLHT 386
                        330
                 ....*....|....*...
gi 528479212 443 FLTPKIFKLGIVKYLKHY 460
Cdd:cd09600  387 LLGEEGFRKGMDLYFERH 404
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
48-463 8.21e-29

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 122.96  E-value: 8.21e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212   48 PDTISPLHYNLLIHPNLTSLDFTGSVQIQIEVLQDTKT-IILHSKNLQISSARLLDaniaQQQPLKVLE-YPYFQQIALV 125
Cdd:TIGR02411   8 YKDFRTSHTDLNLSVDFTKRKLSGSVTFTLKSLTDNLNkLVLDTSYLDIQKVTING----LPADFAIGErKEPLGSPLTI 83
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  126 SDKALLKRGHVYSVELHFAANLSESFHGFYKSTyRTSKGDVRVVAStQFEATSARAAFPCFDEPAFKANFSVQIrrEAKH 205
Cdd:TIGR02411  84 SLPIATSKNDEFVLNISFSTTPKCTALQWLNPE-QTSGKKHPYLFS-QCQAIHARSLFPCQDTPSVKSTYTAEV--ESPL 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  206 IALsnMPKLRTLELKNGLFEDQFDVSVKMSTYLVAYIVSDFLSisktSQHGVQISVYAVPEKID--QAEFALDAAvKLLD 283
Cdd:TIGR02411 160 PVL--MSGIRDGETSNDPGKYLFKQKVPIPAYLIAIASGDLAS----APIGPRSTVYSEPEQLEkcQYEFENDTE-KFIK 232
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  284 FYDDyFDIPYPLPKQDLAAIPD-FQSGAMENWGLTtYRESALLfdphkssASDKLGITmIIAHELAHQWFGNLVTMQWWN 362
Cdd:TIGR02411 233 TAED-LIFPYEWGQYDLLVLPPsFPYGGMENPNLT-FATPTLI-------AGDRSNVD-VIAHELAHSWSGNLVTNCSWE 302
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212  363 DLWLNEGFAKFME--FVSVNITNPELQvedyflgkcFEAM--------EVDSLSSSHPVSTPVEN--PAQIQEMFDDVSY 430
Cdd:TIGR02411 303 HFWLNEGWTVYLErrIIGRLYGEKTRH---------FSALigwgdlqeSVKTLGETPEFTKLVVDlkDNDPDDAFSSVPY 373
                         410       420       430
                  ....*....|....*....|....*....|....
gi 528479212  431 DKGACILNML-REFLTPKIFKLGIVKYLKHYSYQ 463
Cdd:TIGR02411 374 EKGFNFLFYLeQLLGGPAEFDPFLRHYFKKFAYK 407
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
240-464 1.50e-24

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 107.75  E-value: 1.50e-24
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 240 AYIVSDFLSISKTSQHGVQISVYAVPEKIDQAEFALDAAVKLLDFYDDYFdIPYPLPKQDLAAiPDFQSGAMENWGLTTY 319
Cdd:cd09604  205 AWAASPDFVVDAATVDGVTVNVYYLPENAEAAERALEYAKDALEFFSEKF-GPYPYPELDVVQ-GPFGGGGMEYPGLVFI 282
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 320 resallfdpHKSSASDKLGITMIIAHELAHQWFGNLVTmqwwND----LWLNEGFAKFMEFVSVNITNPELQVEDYFLgk 395
Cdd:cd09604  283 ---------GSRLYDPKRSLEGVVVHEIAHQWFYGIVG----NDerrePWLDEGLATYAESLYLEEKYGKEAADELLG-- 347
                        170       180       190       200       210       220
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 528479212 396 cFEAMEVDSLSSSHPVSTPVENPAQIQEMFdDVSYDKGACILNMLREFLTPKIFKLGIVKYLKHYSYQN 464
Cdd:cd09604  348 -RRYYRAYARGPGGPINLPLDTFPDGSYYS-NAVYSKGALFLEELREELGDEAFDKALREYYRRYKFKH 414
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
251-374 1.49e-08

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 58.40  E-value: 1.49e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 251 KTSQHGVQISVYAVPEKIDQAEFALDAAVKLLDFYDDYFdIPYPLP--KQ----DLAAipDFQSGAmenwGLTTYrESAL 324
Cdd:cd09839  290 KLGSSAVEVTGFCLPGRLEELRNTCSFLHKAMDFFEEEY-GSYPFSsyKQvfvdDLPE--DVSSFA----SLSIC-SSRL 361
                         90       100       110       120       130
                 ....*....|....*....|....*....|....*....|....*....|....*..
gi 528479212 325 LFDPHkssasdklgI-------TMIIAHELAHQWFGNLVTMQWWNDLWLNEGFAKFM 374
Cdd:cd09839  362 LYPPD---------IidqayetRRKLAHALASQWFGINIIPKTWSDTWLVIGIAGYM 409
pepN PRK14015
aminopeptidase N; Provisional
257-460 1.50e-08

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 58.60  E-value: 1.50e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 257 VQISVYAVPEKIDQAEFALDA---AVKlldfYD-DYFDIPYplpkqDL-----AAIPDFQSGAMENWGLTTYRESALLFD 327
Cdd:PRK14015 214 VALEIYVEPGNLDKCDHAMDSlkkSMK----WDeERFGLEY-----DLdifmiVAVDDFNMGAMENKGLNIFNSKYVLAD 284
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 528479212 328 PHksSASDK--LGITMIIAHELAHQWFGNLVTMQWWNDLWLNEGFAKF--MEFVS------VN-ITN---------PElq 387
Cdd:PRK14015 285 PE--TATDAdyERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFrdQEFSAdlgsraVKrIEDvrvlraaqfAE-- 360
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 528479212 388 vedyflgkcfeamevDSLSSSHPVstpveNPAQIQEM--FDDVS-YDKGACILNMLREFLTPKIFKLGIVKYLKHY 460
Cdd:PRK14015 361 ---------------DAGPMAHPV-----RPDSYIEInnFYTATvYEKGAEVIRMLHTLLGEEGFRKGMDLYFERH 416
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
338-376 1.30e-05

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 44.78  E-value: 1.30e-05
                         10        20        30        40
                 ....*....|....*....|....*....|....*....|
gi 528479212 338 GITMIIAHELAHQWFGNLVT-MQWWNDLWLNEGFAKFMEF 376
Cdd:cd09594   64 GTIDVLAHELTHAFTGQFSNlMYSWSSGWLNEGISDYFGG 103
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH